Status:

COMPLETED

Dermacyd Tina Gel Tangerina Mix - Photo Evaluation

Lead Sponsor:

Sanofi

Conditions:

Healthy

Eligibility:

FEMALE

18-60 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to prove the absence of photo irritation and photo sensitivity potential of the product Dermacyd Tina Gel Tangerina Mix.

Eligibility Criteria

Inclusion

  • Phototype Skin II and III
  • Integral skin test in the region

Exclusion

  • Lactation or gestation
  • Use of Antiinflammatory and/or immunosuppression drugs 15 days before the selection
  • Diseases which can cause immunity decrease, such as HIV, diabetes
  • Use of drug photosensitizer
  • History of sensitivity or irritation for topic products
  • Active cutaneous disease which can change the study results
  • History or photodermatosis active
  • Family or personal antecedent of cutaneous photoinduced neoplasias
  • Presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and keratoses actinium
  • Intense solar exposure in the study area
  • Use of new drugs or cosmetics during the study
  • The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Key Trial Info

Start Date :

November 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT00668889

Start Date

November 1 2007

Last Update

January 29 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sanofi-aventis administrative office

São Paulo, São Paulo, Brazil

Dermacyd Tina Gel Tangerina Mix - Photo Evaluation | DecenTrialz